cas 69998-14-7|| where to buy 1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione

Product Name:1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione

IUPAC Name:1-(propan-2-yl)-1,3-diazinane-2,4,6-trione

Packing Unit	Available Stock	Price($)
CM337821-100mg	in stock	ƿƿŵ
CM337821-250mg	in stock	ȡŵƿ
CM337821-1g	in stock	ǜƥȐ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 69998-14-7 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:69998-14-7; Molecular Formula:C7H10N2O3; Melting Point:-; Smiles Code:O=C1NC(CC(N1C(C)C)=O)=O; Density:

: Catalog Number:CM337821; Molecular Weight:170.17; Boiling Point:; MDL No:; Storage:

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Mavacamten; CAMZYOS(Mavacamten) was recently approved in the European Union, following its approval in the U.S. and other markets worldwide, and is the first and only cardiac myosin inhibitor approved to treat adult patients with symptomatic obstructive hypertrophic cardiomyopathy(HCM).
Mavacamten is a first-in-class, targeted inhibitor of cardiac myosin, reduces the number of myosin-actin cross-bridges and thus decreases excessive contractility characteristic of HCM.